Lytix Biopharma AS (OSL:LYTIX)
Norway · Delayed Price · Currency is NOK 7.38
+0.18 (2.50%)
Oct 7, 2025, 4:25 PM CET
Lytix Biopharma AS Market Cap
Lytix Biopharma AS has a market cap or net worth of 503.77 million as of October 7, 2025. Its market cap has increased by 28.87% in one year.
Market Cap
503.77M
Enterprise Value
406.17M
Revenue
608.00K
Ranking
n/a
PE Ratio
n/a
Stock Price
7.38
Market Cap Chart
Since June 14, 2021, Lytix Biopharma AS's market cap has decreased from 720.55M to 503.77M, a decrease of -30.08%. That is a compound annual growth rate of -7.95%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 7, 2025 | 503.77M | 25.51% |
| Dec 30, 2024 | 401.38M | 106.12% |
| Dec 29, 2023 | 194.73M | -37.37% |
| Dec 30, 2022 | 310.93M | -41.63% |
| Dec 30, 2021 | 532.66M | -26.08% |
| Jun 14, 2021 | 720.55M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Medistim ASA | 4.33B |
| Nordhealth AS | 2.78B |
| Photocure ASA | 1.56B |
| ArcticZymes Technologies ASA | 1.38B |
| Thor Medical ASA | 1.32B |
| Vistin Pharma ASA | 1.02B |
| Omda AS | 1.00B |
| Gentian Diagnostics ASA | 863.65M |